{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:25:05Z","timestamp":1777440305766,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107876","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:11:03Z","timestamp":1777378263000},"source":"Crossref","is-referenced-by-count":0,"title":["Radiological Presentations of Prostatic Carcinoma Patients: A Retrospective Observational Study From a Tertiary Care Oncology Setup"],"prefix":"10.7759","author":[{"given":"Muhammad O","family":"Altaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunair","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad  M","family":"Niaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Prostate Cancer Statistics 2022. (2026). Accessed. 2026: https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/prostate-cancer-statistics\/."},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20350","article-title":"The prevalence of prostate cancer in Pakistan: a systematic review and meta-analysis","volume":"9","author":"Akhtar S","year":"2023","unstructured":"Akhtar S, Hassan F, Ahmad S, El-Affendi MA, Khan MI. The prevalence of prostate cancer in Pakistan: a systematic review and meta-analysis. Heliyon. 2023, 9:","journal-title":"Heliyon"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar CH","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018, 8:030361. 10.1101\/cshperspect.a030361","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia G","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, et al.. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021, 4:877-92. 10.1016\/j.euo.2021.09.006","journal-title":"Eur Urol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.22.00142","article-title":"Cancer statistics in Pakistan from 1994 to 2021: data from Cancer Registry","volume":"7","author":"Tufail M","year":"2023","unstructured":"Tufail M, Wu C. Cancer statistics in Pakistan from 1994 to 2021: data from Cancer Registry. JCO Clin Cancer Inform. 2023, 7:e2200142. 10.1200\/CCI.22.00142","journal-title":"JCO Clin Cancer Inform"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2019.02.007","article-title":"Contribution of radiology to staging of prostate cancer","volume":"49","author":"Woo S","year":"2019","unstructured":"Woo S, Ghafoor S, Vargas HA. Contribution of radiology to staging of prostate cancer. Semin Nucl Med. 2019, 49:294-301. 10.1053\/j.semnuclmed.2019.02.007","journal-title":"Semin Nucl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03193-0","article-title":"Advanced ultrasound in the diagnosis of prostate cancer","volume":"39","author":"Correas JM","year":"2021","unstructured":"Correas JM, Halpern EJ, Barr RG, et al.. Advanced ultrasound in the diagnosis of prostate cancer. World J Urol. 2021, 39:661-76. 10.1007\/s00345-020-03193-0","journal-title":"World J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2015.01.008","article-title":"Is primary tumor detectable in prostatic carcinoma at routine contrast-enhanced CT?","volume":"39","author":"Schieda N","year":"2015","unstructured":"Schieda N, Al-Dandan O, Shabana W, Flood TA, Malone SC. Is primary tumor detectable in prostatic carcinoma at routine contrast-enhanced CT?. Clin Imaging. 2015, 39:623-6. 10.1016\/j.clinimag.2015.01.008","journal-title":"Clin Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2019-0021","article-title":"Multiparametric MRI - local staging of prostate cancer and beyond","volume":"53","author":"Caglic I","year":"2019","unstructured":"Caglic I, Kovac V, Barrett T. Multiparametric MRI - local staging of prostate cancer and beyond. Radiol Oncol. 2019, 53:159-70. 10.2478\/raon-2019-0021","journal-title":"Radiol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02277-9","article-title":"Genetically adjusted PSA levels for prostate cancer screening","volume":"29","author":"Kachuri L","year":"2023","unstructured":"Kachuri L, Hoffmann TJ, Jiang Y, et al.. Genetically adjusted PSA levels for prostate cancer screening. Nat Med. 2023, 29:1412-23. 10.1038\/s41591-023-02277-9","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.54393\/pbmj.v5i2.229","article-title":"Pattern of presentations and management of complications of metastatic carcinoma prostate in underdeveloped country: complications of metastatic carcinoma prostate","author":"Ullah N","year":"2022","unstructured":"Ullah N, Iqbal Q, Ahmad S, Fareed T, ur Rehman M, ul Wahab M. Pattern of presentations and management of complications of metastatic carcinoma prostate in underdeveloped country: complications of metastatic carcinoma prostate. Pakistan BioMedi J. 2022, 51-4. 10.54393\/pbmj.v5i2.229","journal-title":"Pakistan BioMedi J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.32413\/pjph.v8i3.142","article-title":"Prostate cancer awareness and knowledge; a study of adult men in Lahore Pakistan","volume":"8","author":"Beg BM","year":"2018","unstructured":"Beg BM, Pasha AB, Butt NF, Qureshi SS, Randhawa FA. Prostate cancer awareness and knowledge; a study of adult men in Lahore Pakistan. Pakistan J Pub Health. 2018, 8:128-32. 10.32413\/pjph.v8i3.142","journal-title":"Pakistan J Pub Health"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.29271\/jcpsp.2018.05.409","article-title":"Clinicopathological characteristics of prostate cancer in patients presenting to a tertiary care private sector hospital","volume":"28","author":"Masood A","year":"2018","unstructured":"Masood A, Iqbal N, Shohab D, Hasan A, Aimon S, Mahmood U, Akhter S. Clinicopathological characteristics of prostate cancer in patients presenting to a tertiary care private sector hospital. J Coll Physicians Surg Pak. 2018, 28:409-11.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/iju.iju_27_24","article-title":"Descriptive epidemiology of prostate cancer in India, 2012-2019: Insights from the National Cancer Registry Programme","volume":"40","author":"Sankarapillai J","year":"2024","unstructured":"Sankarapillai J, Krishnan S, Ramamoorthy T, Sudarshan KL, Mathur P. Descriptive epidemiology of prostate cancer in India, 2012-2019: Insights from the National Cancer Registry Programme. Indian J Urol. 2024, 40:167-73. 10.4103\/iju.iju_27_24","journal-title":"Indian J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01427-6","article-title":"Prostate cancer presentation and management in the Middle East","volume":"24","author":"Sayan M","year":"2024","unstructured":"Sayan M, Langoe A, Aynaci O, et al.. Prostate cancer presentation and management in the Middle East. BMC Urol. 2024, 24:35. 10.1186\/s12894-024-01427-6","journal-title":"BMC Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.0.0253","article-title":"Disparities associated with advanced prostate cancer stage at diagnosis","volume":"21","author":"Marlow NM","year":"2010","unstructured":"Marlow NM, Halpern MT, Pavluck AL, Ward EM, Chen AY. Disparities associated with advanced prostate cancer stage at diagnosis. J Health Care Poor Underserved. 2010, 21:112-31. 10.1353\/hpu.0.0253","journal-title":"J Health Care Poor Underserved"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, et al.. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014, 74:210-6. 10.1002\/pros.22742","journal-title":"Prostate"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23492","article-title":"The prognosis of different distant metastases pattern in prostate cancer: a population based retrospective study","volume":"78","author":"Shou J","year":"2018","unstructured":"Shou J, Zhang Q, Wang S, Zhang D. The prognosis of different distant metastases pattern in prostate cancer: a population based retrospective study. Prostate. 2018, 78:491-7. 10.1002\/pros.23492","journal-title":"Prostate"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228447","article-title":"Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study","volume":"15","author":"Thomsen FB","year":"2020","unstructured":"Thomsen FB, Westerberg M, Garmo H, Robinson D, Holmberg L, Ulmert HD, Stattin P. Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study. PLoS One. 2020, 15:e0228447. 10.1371\/journal.pone.0228447","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.08.002","article-title":"PSA doubling time and absolute PSA predict metastasis-free survival in men with biochemically recurrent prostate cancer after radical prostatectomy","volume":"17","author":"Markowski MC","year":"2019","unstructured":"Markowski MC, Chen Y, Feng Z, et al.. PSA doubling time and absolute PSA predict metastasis-free survival in men with biochemically recurrent prostate cancer after radical prostatectomy. Clin Genitourin Cancer. 2019, 17:470-5. 10.1016\/j.clgc.2019.08.002","journal-title":"Clin Genitourin Cancer"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P","article-title":"Risk of prostate carcinoma death in patients with lymph node metastasis","volume":"91","author":"Cheng L","year":"2001","unstructured":"Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer. 2001, 91:66-73.","journal-title":"Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01547","article-title":"Risk factors for pathologically confirmed lymph nodes metastasis in patients with clinical T2N0M0 stage prostate cancer","volume":"10","author":"Xu N","year":"2020","unstructured":"Xu N, Ke ZB, Chen YH, et al.. Risk factors for pathologically confirmed lymph nodes metastasis in patients with clinical T2N0M0 stage prostate cancer. Front Oncol. 2020, 10:1547. 10.3389\/fonc.2020.01547","journal-title":"Front Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2023.07.001","article-title":"PSMA PET\/CT for primary staging of prostate cancer - an updated overview","volume":"54","author":"Jochumsen MR","year":"2024","unstructured":"Jochumsen MR, Bouchelouche K. PSMA PET\/CT for primary staging of prostate cancer - an updated overview. Semin Nucl Med. 2024, 54:39-45. 10.1053\/j.semnuclmed.2023.07.001","journal-title":"Semin Nucl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416809-radiological-presentations-of-prostatic-carcinoma-patients-a-retrospective-observational-study-from-a-tertiary-care-oncology-setup","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:11:05Z","timestamp":1777378265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416809-radiological-presentations-of-prostatic-carcinoma-patients-a-retrospective-observational-study-from-a-tertiary-care-oncology-setup"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.107876","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}